AI-powered search

Topical roflumilast is indicated for patients 12 years and older. What is the significance of this as you think about topical treatment options for patients?

Featuring Andrew Alexis, MD, MPH |

Vice-Chair for Diversity and Inclusion, Dept. of Dermatology
Professor of Clinical Dermatology 
Weill Cornell Medicine
New York, NY

| Published September 29, 2022

Loading...

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved